RxVigilance Mobile

Veröffentlicht von: Vigilance Sante

Beschreibung

RxVigilance - a reference tool for health care professionals that features information on drugs and health - can now be accessed from anywhere.
After installation, THE APPLICATION RESIDES ENTIRELY ON THE DEVICE and does not require an Internet connection for regular use. Internet access is required for updates.
Already used by thousands of physicians, pharmacists, nurses and other health care professionals across Canada, RxVigilance provides you with relevant and up to date information from several dozen leading reference sources. Drug monographs, pharmacological profile analysis, and information on natural products and travel destinations are among some of the many features you can now access through your device.
Our team of health care professionals is well aware of your day to day information needs. As a result, they are equipped to select what is most useful and relevant for you and your practice and to integrate that information to RxVigilance. In short, you will be able to access what you need quickly and effectively.
The RxVigilance Mobile App includes access to:
COMPARATIVE CHARTS
In the application users will find a series of charts comparing the characteristics of products from the same pharmacological class in order to help them make the best therapeutic decision based on onset of action or the number of administrations a day, for example.
MONOGRAPHS
Professional information on more than 1200 drugs. You can find information on adverse reactions, official and unofficial indications, adult dosages, pediatric dosages, geriatric dosages, adjustments for renal and hepatic impairment, precautions in pregnancy/breastfeeding, special precautions (grapefruit, stability, food, etc.), contraindications, interactions and kinetics. Monographs are regularly updated with information deemed relevant by our team of professionals.
TRAVEL
This feature allows to search for over 200 destinations. It provides access to brief and relevant overview of the destination (currency, languages, population, capital), required and/or recommended immunizations by country, recommendations based on diseases found in each country and contact details for service centres that may be of use while traveling.
NATURAL PRODUCTS
Information on more than 60 of the most commonly used natural products. It includes product indications (classified by evidence of effectiveness), product description and discussion on product safety and efficacy.
PROFILE ANALYSIS
Profile analysis allows to identify interactions and provides a description of the interactions as well as recommendations. Interactions are classified by importance of actions to be taken by the professional.
BULLETINS
Monthly communiqué for subscribers with details on the most recent updates and new developments and a list of monographs to which changes have been made. It is possible to refer to bulletins from prior months and send questions or comments via e-mail to the Rx Vigilance team.
PHONE DIRECTORY
A phone directory that consists of over 6000 useful contacts such as: hospitals, CLSCs, support groups and self-help groups, pharmacies, pharmaceutical companies, etc. It allows users to dial phone numbers directly from their iPhone and to acces links to internet sites when available.
Ausblenden Mehr anzeigen...

Screenshots

RxVigilance Mobile Häufige Fragen

  • Ist RxVigilance Mobile kostenlos?

    Ja, RxVigilance Mobile ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist RxVigilance Mobile seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet RxVigilance Mobile?

    RxVigilance Mobile ist kostenlos.

  • Wie hoch ist der Umsatz von RxVigilance Mobile?

    Um geschätzte Einnahmen der RxVigilance Mobile-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Algerien noch nicht bewertet.
Bewertungsverlauf

RxVigilance Mobile Bewertungen

Informations incompletes

straia002 on

Kanada

L’usage de l’application est tres limitée et les informations sont incompletes. Toutes les interactions ne sont pas indiquées. Je ne recommande pas l’application pour usage professionel car l’analyse des interactions est des informations est incomplete et s’avere donc faux et dangereux

Opening the app is too long

tdiamond1 on

Kanada

Openinh the app each time takes 10 sec, there’s a image download, its too long , please fix that

Ne fonctionne plus

KinfuaM on

Kanada

Connexion impossible depuis la dernière mise à jour, ne reconnaît malheureusement plus mon compte

Mise à jour

Bobol655 on

Kanada

L’application ne fonctionne plus depuis la dernière mise à jour.

Drug coverage and annex

watsonpascal on

Kanada

I think you should add drug coverage and the annex i think it’s a good part off your product

Best App for Pharmacists

StarAcademieCanada on

Kanada

User friendly, info is found quickly which is ideal for professionals working in a fast pace environment.

doesnt work

mchan06 on

Kanada

tried to renew subscription. click renew button but nothing happens

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
Diagramm
Kategorie
Rang
Top Umsatz
20

RxVigilance Mobile Installationen

Letzte 30 Tage

RxVigilance Mobile Umsatz

Letzte 30 Tage

RxVigilance Mobile Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von RxVigilance Mobile mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.